Cardiovascular - Phase2 (1)
|
Modality |
Indication |
Targets |
Stage |
Company |
Project No. |
Detail |
| 1 |
Phase II clinical development of DPP-4 inhibitor (Evogliptin), a new drug for medical treatment of Aortic Stenosis |
| Small molecules |
Aortic Stenosis |
DPP-4 |
Phase 2 |
REDNVIA |
HN21C1047 |
|